PWAR5 and thyroid gland carcinoma: In conclusion, our findings demonstrate that PAR5 downregulation was strictly related to the undifferentiated thyroid carcinomas and that PAR5 expression affected cell growth and migration rate by interacting with EZH2 and inhibiting its oncogenic activity.